Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Current Leases: 2019-2022

Historic Current Leases for Aytu Biopharma (AYTU) over the last 2 years, with Mar 2022 value amounting to $1.2 million.

  • Aytu Biopharma's Current Leases rose 32.07% to $1.2 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.2 million, marking a year-over-year increase of 32.07%. This contributed to the annual value of $940,000 for FY2021, which is 213.33% up from last year.
  • Per Aytu Biopharma's latest filing, its Current Leases stood at $1.2 million for Q1 2022, which was up 2.56% from $1.2 million recorded in Q4 2021.
  • Aytu Biopharma's 5-year Current Leases high stood at $1.2 million for Q1 2022, and its period low was $79,362 during Q3 2019.
  • In the last 3 years, Aytu Biopharma's Current Leases had a median value of $925,442 in 2021 and averaged $726,076.
  • Data for Aytu Biopharma's Current Leases shows a peak YoY skyrocketed of 1,069.92% (in 2021) over the last 5 years.
  • Quarterly analysis of 4 years shows Aytu Biopharma's Current Leases stood at $82,755 in 2019, then rose by 21.16% to $100,263 in 2020, then skyrocketed by 1,069.92% to $1.2 million in 2021, then skyrocketed by 32.07% to $1.2 million in 2022.
  • Its Current Leases stands at $1.2 million for Q1 2022, versus $1.2 million for Q4 2021 and $1.1 million for Q3 2021.